{'fraction_non_alphanumeric': 0.025680933852140077, 'fraction_numerical': 0.0015564202334630351, 'mean_word_length': 5.242718446601942, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
C/EBPδ demonstrates a dichotomous role in tumor initiation and promotion of epithelial carcinoma

C/EBPδ (CEBPD), a gene part of the highly conserved basic-leucine zipper (b-ZIP) domain of transcriptional factors, is downregulated in 65% of high grade serous carcinoma of the ovary (HGSC). Overexpression of C/EBPδ in different tumors as glioblastoma and breast cancer either promotes tumor progression or inhibits growth. Despite these contradictory roles in different cancer types, we show that C/EBPδ overexpression has a consistent function of downregulating proliferation and promoting migration in fallopian tube epithelial cells (FTE). We show that the FTE have both mesenchymal and epithelial cell characteristics. Further, our data supports a role for C/EBPδ as an early regulatory transcriptional factor that promotes a mesenchymal to epithelial (MET) phenotype by upregulating E-cadherin and downregulating vimentin and N-cadherin in FTE cells. We demonstrate that overexpression of C/EBPδ in ovarian and breast cancer cell lines have consistent effects and phenotype as the FTE cells. Our findings suggest a role for C/EBPδ in the early events of ovarian serous carcinogenesis which may be used to help further understand how the disease develops from a premalignant cells.